Código QR (código de barras bidimensional)

Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers

ObjectiveThe myosin-binding protein C (MYBPC3) c.927-2A>G founder mutation accounts for >90% of sarcomeric hypertrophic cardiomyopathy (HCM) in Iceland. This cross-sectional observational study explored the penetrance and phenotypic burden among carriers of this single, prevalent founder mutat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Principais autores: Javier Diez, Begoña López, Barry J Maron, Berglind Adalsteinsdottir, Michael Burke, Ragnar Danielsen, Petr Jarolim, Jonathan Seidman, Christine E. Seidman, Carolyn Y Ho, Gunnar Th Gunnarsson
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2020-06-01
Serier:Open Heart
Online adgang:https://openheart.bmj.com/content/7/1/e001220.full
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!